In this review:
This review summarises the evidence supporting the use of Synthroid® (levothyroxine) for treatment of hypothyroidism. Synthroid is fully funded and is available in three tablet strengths 25 mcg, 50 mcg and 100 mcg. Dosing of Synthroid is determined by a combination of clinical assessment, patient body mass and laboratory monitoring. This review is sponsored by an educational grant from Viatris.
Please login below to download this issue (PDF)